ArticleRadiation oncology (London, England)2014

Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy.

Stefan Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.